CPMD (Cannapharmarx) Shiller PE Ratio: (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cannapharmarx Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cannapharmarx  (OTCPK:CPMD) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cannapharmarx Shiller PE Ratio Related Terms


Cannapharmarx Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Cannapharmarx's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannapharmarx Shiller PE Ratio Chart

Cannapharmarx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cannapharmarx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CPMD vs PLSH, SHPH, SKYI: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannapharmarx's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannapharmarx Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannapharmarx's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cannapharmarx's Shiller PE Ratio falls into.



Cannapharmarx Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cannapharmarx's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Cannapharmarx's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/133.5265*133.5265
=0.000

Current CPI (Jun. 2026) = 133.5265.

Cannapharmarx Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.002 101.765 -0.003
201612 -0.010 101.449 -0.013
201703 0.000 102.634 0.000
201706 0.000 103.029 0.000
201709 0.000 103.345 0.000
201712 0.000 103.345 0.000
201803 0.000 105.004 0.000
201806 -0.004 105.557 -0.005
201809 -0.060 105.636 -0.076
201812 -0.110 105.399 -0.139
201903 -0.050 106.979 -0.062
201906 -0.023 107.690 -0.029
201909 -0.270 107.611 -0.335
201912 -0.280 107.769 -0.347
202003 -0.120 107.927 -0.148
202006 -0.040 108.401 -0.049
202009 -0.070 108.164 -0.086
202012 -0.290 108.559 -0.357
202103 0.020 110.298 0.024
202106 -0.030 111.720 -0.036
202109 -0.010 112.905 -0.012
202112 -0.100 113.774 -0.117
202203 -0.010 117.646 -0.011
202206 -0.010 120.806 -0.011
202209 -0.005 120.648 -0.006
202212 -0.020 120.964 -0.022
202303 -0.005 122.702 -0.005
202306 -0.010 124.203 -0.011
202309 -0.002 125.230 -0.002
202312 0.020 125.072 0.021
202403 -0.030 126.258 -0.032
202406 0.010 127.522 0.010
202409 0.000 127.285 0.000
202412 -0.010 127.364 -0.010
202503 0.000 129.181 0.000
202506 0.000 129.892 0.000
202509 0.000 130.287 0.000
202512 -0.010 130.366 -0.010
202603 0.000 132.262 0.000
202606 0.000 133.527 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cannapharmarx Business Description

Address 4439 Township Road 304, Suite 302, Mountain View County, Central Alberta, AB, CAN, T0M 0R0
Cannapharmarx Inc specializes in the acquisition, development, and operation of cannabis cultivation facilities in Canada. The group evolved to focus on producing medical cannabis and craft products. The products of the company are Unique Genetics, Craft Products, and Medical Cannabis.